Briefly speaking, the associations between the levels of FGF-21 and the renal outcomes in our study suggested that FGF-21 can be a potential marker used in clinical practice to predict the progression of DKD in subjects with T2DM. The gene discussed is FGF21; the disease is diabetic kidney disease.